Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDArcadia Biosciences Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.80 | -$0.80 | -$0.80 |
| Q2 2026 | 1 | -$0.56 | -$0.56 | -$0.56 |
| Q3 2026 | 1 | -$0.46 | -$0.46 | -$0.46 |
| Q4 2026 | 1 | -$0.60 | -$0.60 | -$0.60 |
Arcadia Biosciences Inc Earnings Date And Information
Arcadia Biosciences Inc last posted its earnings results on Thursday, March 26th, 2026. The company reported $-0.98 earnings per share for the quarter, missing analysts' consensus estimates of $-0.66 by $0.32. The company had revenue of 901.00 K for the quarter and had revenue of 4.86 M for the year. Arcadia Biosciences Inc has generated $-2 earnings per share over the last year ($-1.71 diluted earnings per share) and currently has a price-to-earnings ratio of -0.68. Arcadia Biosciences Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Arcadia Biosciences Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/26/2026 | Q4 2025 | -$0.66 | -$0.98 | -0.32 | $1.40 M | $901.00 K |
| 11/07/2025 | Q3 2025 | -$0.54 | $0.62 | 1.16 | $1.90 M | $1.30 M |
| 08/14/2025 | Q2 2025 | -$0.79 | -$3.26 | -2.47 | $1.60 M | $1.46 M |
| 05/08/2025 | Q1 2025 | -$0.98 | $1.90 | 2.88 | $1.30 M | $1.20 M |
| 04/30/2025 | Q4 2024 | N/A | -$1.18 | N/A | $1.15 M | $1.22 M |
| 11/12/2024 | Q3 2024 | -$0.77 | -$1.18 | -0.41 | $1.40 M | $1.54 M |
| 08/13/2024 | Q2 2024 | $1.55 | $0.78 | -0.77 | $950.00 K | $1.31 M |
| 05/13/2024 | Q1 2024 | N/A | -$1.78 | N/A | $1.20 M | $987.00 K |
| 04/29/2024 | Q4 2023 | N/A | -$2.22 | N/A | N/A | $1.17 M |
| 11/09/2023 | Q3 2023 | -$2.67 | -$1.89 | 0.78 | N/A | $1.30 M |
| 08/10/2023 | Q2 2023 | -$4.92 | $0.60 | 5.52 | N/A | $1.30 M |
| 05/15/2023 | Q1 2023 | -$6.35 | -$4.45 | 1.9 | N/A | $1.23 M |
| 03/30/2023 | Q4 2022 | $6.80 | -$7.03 | -13.83 | N/A | $1.00 M |
| 11/10/2022 | Q3 2022 | -$7.60 | -$4.82 | 2.78 | N/A | $1.57 M |
| 08/11/2022 | Q2 2022 | -$12.40 | -$6.81 | 5.59 | N/A | $3.86 M |
| 05/12/2022 | Q1 2022 | -$12.40 | -$8.07 | 4.33 | N/A | $3.22 M |
| 03/31/2022 | Q4 2021 | N/A | -$0.42 | N/A | N/A | $2.17 M |
| 11/15/2021 | Q3 2021 | -$9.20 | -$4.00 | 5.2 | N/A | $2.38 M |
| 08/16/2021 | Q2 2021 | -$9.20 | -$9.68 | -0.48 | N/A | $1.41 M |
| 05/17/2021 | Q1 2021 | -$12.40 | $4.40 | 16.8 | N/A | $828.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Arcadia Biosciences Inc Earnings: FAQ's
The conference call for Arcadia Biosciences Inc's latest earnings report can be listened to online.
The conference call transcript for Arcadia Biosciences Inc's latest earnings report can be read online.
Arcadia Biosciences Inc (:RKDA) has a recorded annual revenue of $4.86 M.
Arcadia Biosciences Inc (:RKDA) has a recorded net income of $-2,339,000.Arcadia Biosciences Inc has generated $-1.71 earnings per share over the last four quarters.
Arcadia Biosciences Inc (:RKDA) has a price-to-earnings ratio of -0.68 and price/earnings-to-growth ratio is 0.